ROBIN BURROUGH: Open Payments
NPI 1942660329 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 14 payments from 6 companies in 2025. Trend: 2023 $254 · 2024 $489 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $160 |
| Lilly USA, LLC | 4 | $153 |
| Ardelyx, Inc. | 1 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $114 |
| Abbott Laboratories | 1 | $77 |
| Axsome Therapeutics, Inc. | 3 | $72 |
Products named: VRAYLAR, MOUNJARO, IBSRELA, XIFAXAN, FREESTYLE LIBRE 3, Auvelity, JARDIANCE, QULIPTA.
Industry payments across LA — which companies pay providers there.
